HR
MGNX icon

Howe & Rusling’s MacroGenics MGNX Stock Holding History

Howe & Rusling’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed – – 741
2022
Q3 		$0 Buy
45
+18
+67% +$69 ﹤0.01% 1141
2022
Q2 		$0 Hold
27
– – ﹤0.01% 1125
2022
Q1 		$0 Sell
27
-8
-23% -$88 ﹤0.01% 1048
2021
Q4 		$1K Hold
35
– – ﹤0.01% 938
2021
Q3 		$1K Buy
35
+4
+13% +$96 ﹤0.01% 927
2021
Q2 		$1K Hold
31
– – ﹤0.01% 889
2021
Q1 		$1K Sell
31
-6
-16% -$146 ﹤0.01% 895
2020
Q4 		$1K Buy
+37
New +$852 ﹤0.01% 885

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Howe & Rusling's MGNX Position: Q4 2022 in Review

Howe & Rusling sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 45 shares.

Howe & Rusling first reported a position in MGNX in Q4 2020 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Howe & Rusling reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 45 MacroGenics shares in Q4 2022.
  • Howe & Rusling first reported a position in MacroGenics in Q4 2020 and held it in 8 quarters.
  • Howe & Rusling's MacroGenics position peaked at $1K in Q4 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.